Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma

International Journal of Oncology

Volumn 30, Issue 5, 2007, Pages 1205-1214

  Heinsohn, Susanne ^a   Ulrike, Evermann ^a   Udo, Zur Stadt ^a   Bielack, Stefan ^b,c   Kabisch, Hartmut ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b OLGAHOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Denaturing high performance liquid chromatography; Loss of heterozygosity; Osteosarcoma; Retinoblastoma gene

Indexed keywords

ANTINEOPLASTIC AGENT; MICROSATELLITE DNA; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CHILD; FEMALE; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MALE; OSTEOSARCOMA; PRESCHOOL CHILD; PROGNOSIS;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, AGAR GEL; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; OSTEOSARCOMA; POLYMORPHISM, GENETIC; PROGNOSIS; RETINOBLASTOMA PROTEIN;

EID: 34447326491     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.5.1205     Document Type: Article

References (51)

1. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jurgens H and Winkler K: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20: 776-790, 2002. (Pubitemid 34111386)
2. Goodrich DW and Lee WH: Molecular characterization of the retinoblastoma susceptibility gene. Biochim Biophys Acta 1155: 43-61, 1993. (Pubitemid 23163750)
3. Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW and Dryja TP: Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 17: 535-543, 1993. (Pubitemid 23282803)
4. Weinberg RA: The Rb gene and the negative regulation of cell growth. Blood 74: 529-532, 1989. (Pubitemid 19208788)
5. Weinberg RA: The retinoblastoma gene and cell growth control. Trends Biochem Sci 15: 199-202, 1990. (Pubitemid 20190929)
6. Hatakeyama M and Weinberg RA: The role of RB in cell cycle control. Prog Cell Cycle Res 1: 9-19, 1995.
7. Fung YK, T'Ang A and Thompson TL: Molecular biology of the human retinoblastoma gene. Cancer Treat Res 47: 303-318, 1989. (Pubitemid 19109752)
8. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM and Dryja TP: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646, 1986. (Pubitemid 16008560)
9. Eisenberg MB, Woloschak M, Sen C and Wolfe D: Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas. Surg Neurol 47: 156-161, 1997. (Pubitemid 27074169)
10. Huang Y, Boynton RF, Blount PL, et al: Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52: 6525-6530, 1992.
11. Kim JW, Lee CG, Han SM, Kim KS, Kim JO, Lee JM, Kim IK and Namkoong SE: Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection. Gynecol Oncol 67: 215-221, 1997. (Pubitemid 27500423)
12. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD and Kaye FJ: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241: 353-357, 1988.
13. Ookawa K, Shiseki M, Takahashi R, Yoshida Y, Terada M and Yokota J: Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations. Oncogene 8: 2175-2181, 1993. (Pubitemid 23226951)
14. Ishikawa J, Xu HJ, Hu SX, Yandell DW, Maeda S, Kamidono S, Benedict WF and Takahashi R: Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 51: 5736-5743, 1991.
15. T'Ang A, Varley JM, Chakraborty S, Murphree AL and Fung YK: Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 242: 263-266, 1988.
16. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y and Yamamuro T: Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54: 3042-3048, 1994. (Pubitemid 24187793)
17. Scholz RB, Kabisch H, Weber B, Roser K, Delling G and Winkler K: Studies of the RB1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Oncol 9: 125-137, 1992.
18. Toguchida J, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y and Yamamuro T: Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 48: 3939-3943, 1988.
19. Belchis DA, Meece CA, Benko FA, Rogan PK, Williams RA and Gocke CD: Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomas. Diagn Mol Pathol 5: 214-219, 1996. (Pubitemid 26323983)
20. Feugeas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P, Babin S, Thyss A, Hofman P, Terrier P, Kalifa C, Brunat-Mentigny M, Patricot LM and Oberling F: Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14: 467-472, 1996. (Pubitemid 26051009)
21. Markaki EA, Tsopanomichalou M, Dimitriou H, Stiakaki E, Perdikoyanni C, Spandidos D and Kalmanti M: Mutations of retinoblastoma gene (Rb-1) as a prognostic factor in children with acute leukemia and neuroblastoma. Pediatr Hematol Oncol 18: 101-110, 2001.
22. Knudson AG: Two genetic hits (more or less) to cancer. Nat Rev Cancer 1: 157-162, 2001.
23. Weichselbaum RR, Beckett M and Diamond A: Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology. Proc Natl Acad Sci USA 85: 2106-2109, 1988.
24. Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brogger A, Gedde-Dahl T and Cavenee WK: Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 82: 6216-6220, 1985.
25. Salzer-Kuntschik M, Delling G, Beron G and Sigmund R: Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80. J Cancer Res Clin Oncol 106 (suppl): 21-24, 1983.
26. Salzer-Kuntschik M, Brand G and Delling G: Bestimmung des morphologischen Regressionsgrades nach Chemotherapie bei malignen Knochentumoren. Pathologie 4: 135-141, 1983.
27. zur Stadt U, Rischewski J, Schneppenheim R and Kabisch H: Denaturing HPLC for identification of clonal T-cell receptor gamma rearrangements in newly diagnosed acute lymphoblastic leukemia. Clin Chem 47: 2003-2011, 2001.
28. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Statist Assoc 53: 457-481, 1958.
29. Goto A, Kanda H, Ishikawa Y, Matsumoto S, Kawaguchi N, Machinami R, Kato Y and Kitagawa T: Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas. Jpn J Cancer Res 89: 539-547, 1998.
30. Patino-García A, Pineiro ES, Diez MZ, Iturriagagoitia LG, Klussmann FA and Ariznabarreta LS: Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas. J Pediatr Hematol Oncol 25: 362-367, 2003.
31. Peltomaki P, Lothe RA, Aaltonen LA, et al: Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53: 5853-5855, 1993.
32. Loeb LA: Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54: 5059-5063, 1994.
33. Karachristos A, Liloglou T, Field JK, Deligiorgi E, Kouskouni E and Spandidos DA: Microsatellite instability and p53 mutations in hepatocellular carcinoma. Mol Cell Biol Res Commun 2: 155-161, 1999.
34. Sourvinos G, Parissis J, Sotsiou F, Arvanitis DL and Spandidos DA: Detection of microsatellite instability in sporadic cardiac myxomas. Cardiovasc Res 42: 728-732, 1999.
35. Froudarakis ME, Sourvinos G, Fournel P, Bouros D, Vergnon JM, Spandidos DA and Siafakas NM: Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer. Chest 113: 1091-1094, 1998.
36. Sourvinos G, Kiaris H, Tsikkinis A, Vassilaros S and Spandidos DA: Microsatellite instability and loss of heterozygosity in primary breast tumours. Tumour Biol 18: 157-166, 1997. (Pubitemid 27204762)
37. Hatzistamou J, Kiaris H, Ergazaki M and Spandidos DA: Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun 225: 186-190, 1996. (Pubitemid 26285417)
38. Field JK, Kiaris H, Howard P, Vaughan ED, Spandidos DA and Jones AS: Microsatellite instability in squamous cell carcinoma of the head and neck. Br J Cancer 71: 1065-1069, 1995.
39. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT and Boyd J: Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 53: 5100-5103, 1993.
40. Yee CJ, Roodi N, Verrier CS and Parl FF: Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 54: 1641-1644, 1994.
41. Siafakas NM, Tzortzaki EG, Sourvinos G, Bouros D, Tzanakis N, Kafatos A and Spandidos D: Microsatellite DNA instability in COPD. Chest 116: 47-51, 1999.
42. Vassilakis DA, Sourvinos G, Markatos M, Psathakis K, Spandidos DA, Siafakas NM and Bouros D: Microsatellite DNA instability and loss of heterozygosity in pulmonary sarcoidosis. Am J Respir Crit Care Med 160: 1729-1733, 1999.
43. Paraskakis E, Sourvinos G, Passam F, Tzanakis N, Tzortzaki EG, Zervou M, Spandidos D and Siafakas NM: Microsatellite DNA instability and loss of heterozygosity in bronchial asthma. Eur Respir J 22: 951-955, 2003.
44. Martin SS, Hurt WG, Hedges LK, Butler MG and Schwartz HS: Microsatellite instability in sarcomas. Ann Surg Oncol 5: 356-360, 1998.
45. Paulson TG, Wright FA, Parker BA, Russack V and Wahl GM: Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56: 4021-4026, 1996.
46. Ozaki T, Schaefer KL, Wai D, Buerger H, Flege S, Lindner N, Kevric M, Diallo R, Bankfalvi A, Brinkschmidt C, Juergens H, Winkelmann W, Dockhorn-Dworniczak B, Bielack SS and Poremba C: Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas. Int J Cancer 102: 355-365, 2002.
47. Onda M, Matsuda S, Higaki S, Iijima T, Fukushima J, Yokokura A, Kojima T, Horiuchi H, Kurokawa T and Yamamoto T: ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma. Cancer 77: 71-78, 1996.
48. Akatsuka T, Wada T, Kokai Y, Kawaguchi S, Isu K, Yamashiro K, Yamashita T, Sawada N, Yamawaki S and Ishii S: ErbB2 expression is correlated with increased survival of patients with osteosarcoma. Cancer 94: 1397-1404, 2002.
49. Munier FL, Thonney F, Balmer A, Uffer S, Heon E, van Melle G, Rutz HP, Pescia G and Schorderet DF: Prognostic factors associated with loss of heterozygosity at the RB1 locus in retinoblastoma. Ophthalmic Genet 18: 7-12, 1997.
50. Brandt B, Greger V, Yandell D, Passarge E and Horsthemke B: A simple and nonradioactive method for detecting the Rb1.20 DNA polymorphism in the retinoblastoma gene. Am J Hum Genet 51: 1450-1451, 1992.
51. Bookstein R, Lai CC, To H and Lee WH: PCR-based detection of a polymorphic BamHI site in intron 1 of the human retinoblastoma (RB) gene. Nucleic Acids Res 18: 1666, 1990.